MELBOURNE, Australia, May 31, 2024 Immuron Limited , an Australian based and globally integrated biopharmaceutical company, is pleased to advise our Chief Executive Officer Steven Lydeamore will.
MELBOURNE, Australia, May 31, 2024 Immuron Limited , an Australian based and globally integrated biopharmaceutical company, advises that Dr Roger Aston has resigned from his position as.
MELBOURNE, Australia, May 31, 2024 (GLOBE NEWSWIRE) Immuron Limited ((ASX: IMC, NASDAQ:IMRN), an Australian based and globally integrated biopharmaceutical company, advises that Dr Roger Aston has resigned from his
MELBOURNE, Australia, May 31, 2024 (GLOBE NEWSWIRE) Immuron Limited ((ASX: IMC, NASDAQ:IMRN), an Australian based and globally integrated biopharmaceutical company, is pleased to advise our Chief Executive Officer
MELBOURNE, Australia, May 03, 2024 Immuron Limited , an Australian based and globally integrated biopharmaceutical company, advises that Stephen Anastasiou has resigned from his position as.